Derm-Biome Pharmaceuticals is a Vancouver-based biopharmaceutical company focused on creating treatments that support healthy skin and slow signs of ageing. The team studies how inflammation, bacteria and cell damage contribute to skin problems, and develops topical therapies that aim to be both effective and gentle on the skin. Their work includes early research on compounds that reduce irritation, protect against sun-related damage and encourage collagen production. In addition to ageing concerns, the company is also exploring treatments for inflammatory skin conditions and early-stage skin cancers. Their goal is to provide science-based solutions that improve long-term skin health.